Cerise ad: The Endocrinologist Became The Patient😭💔

I don't give a f*ck if this upsets you. I am going to say something that nobody with chronic mold illness wants to hear. I diagnosed my 2,316th patient with Hashimoto's on August 23rd, 2024. Twenty-nine days later, at 4:52 AM on September 21st, I was being driven to my own emergency endocrinology appointment with the base of my throat swelling fast enough that my husband could watch it change under the dome light of the car. I was 53 years old. I am a board-certified endocrinologist. Twenty-one years of practice. A full thyroid panel ordered by a colleague I had trained six years earlier. I could not swallow my own saliva without flinching in the parking lot. The initial workup bill was $39,200. Follow-up imaging and labs were another $12,400. They will let me practice again. My hospital privileges are intact. But I will never write the word "Hashimoto's" on another chart without remembering that I was in that same exam room with someone I had trained running a thyroid ultrasound over my own neck because everything I had been prescribing for twenty years had not saved me. I am writing this because I know exactly what my colleagues will say when they see it. I do not care. If you are over 40 and you have been told your thyroid is "managed on levothyroxine," or someone you love has, please read the entire thing. I know it is long. I know you are scrolling. I know you have things to do. Fourteen months ago I would have given anything for someone with my credential to sit me down and tell me what I am about to tell you. Nobody did. I was diagnosed with mold toxicity four years ago at 49. Elevated ochratoxin A on a urine mycotoxin panel. Elevated gliotoxin. Rising TPO antibodies. The whole mycotoxin-driven endocrine signature. The diagnosis surprised me and it did not. My best friend from medical school, the endocrinologist who was my roommate during residency, had died at 46 of "Hashimoto's complications and thyroid storm, cause of trigger undetermined" after five years of brain fog, cold hands, hair thinning, 3am wake-ups, and weight gain that nobody connected to the water-damaged basement office she had been seeing patients in for the last eight years of her career. Her endocrinologist had kept adjusting her levothyroxine dose for five years while her TPO antibodies climbed from 180 to 2,400. She died in a hotel room on a conference trip at 46. I had watched the pattern in the woman I had studied with and I had built my entire endocrinology practice on treating the mold-driven thyroid attacks of patients who looked like her. I did what any endocrinologist with a functional medicine certificate would prescribe. I started cholestyramine at diagnosis. My colleague, another endocrinologist in my own practice who had added functional training, added CellCore binders the following year when my ochratoxin stalled. She added a sauna protocol the year after that when my inflammatory markers started climbing. Three interventions. Two of them protocols I had personally prescribed to hundreds of my own patients. I remediated my house. I threw away the furniture. I stopped drinking. I slept with an air purifier running. I ate the anti-inflammatory diet I recommend to every patient after a mold-driven endocrine attack. Pastured protein. Olive oil. Leafy greens. Minimal refined sugar. I ran a full mycotoxin panel on myself the year I was diagnosed. Mild to moderate load. I checked every box on my own protocol. By last July, my ochratoxin A had come down modestly. My gliotoxin had held steady. My TSH was in range on levothyroxine. My symptoms were "stable." By the standard of the guidelines I had helped write for our practice group, I was managed. Managed. That word again. I ran a second full panel on myself last July, four years after the first one. I did it because a hunch would not leave me alone. My ochratoxin A had crept back up to 11.1. My gliotoxin had risen from 2.3 to 4.9. My TPO antibodies had climbed from 320 to 940. My reverse T3 was the highest it had ever been. For context, I have called patients into my office with panels half that bad and used the sentence, we need to escalate your protocol today, not next week. I called my colleague and asked her to review my labs. She did. She was concerned. She recommended a thyroid ultrasound and a repeat full panel to be safe. I scheduled them. And then I did not go. I want to tell you why. Because sitting in my office at 7 PM staring at my own labs on my own screen, I recognized something. I was doing exactly what my best friend Priya had done. She had been "managed" on levothyroxine for five years before the thyroid storm that killed her. Her TSH had been in range the entire time. Her charts had read fine. Her numbers had been "acceptable." And she had died in a hotel bathroom at 46 with a heart rate of 210. I did not go to my own thyroid ultrasound because I already knew what it would show. I did not want to see it in writing. I told myself I had time. Twenty-nine days later my husband was driving me to the hospital at 5 AM with his left hand on the wheel and his right hand on my knee. The swelling started at the base of my throat at 4:36 AM. I remember the time because I looked at my bedside clock and thought, this is not just a bad night of sleep. It was not. It was the anterior neck swelling I had described to a thousand patients in follow-up appointments. Soft. Hot. Visible under the collar of my pajama shirt in the mirror. A heart racing lying still at 128. My husband, a civil engineer, sat up before I could finish the sentence. He is not a physician but he has heard me describe this exact presentation at our kitchen table for twenty years. He drove me. We went to a competing academic medical center, not my own. Because I did not want the residents I had trained to see me in that chair. They saw me anyway. The endocrinologist on call was a woman I had trained through her fellowship in 2018. She walked into the ER bay, saw me sitting with my chin tilted back because the pressure in my throat was easier that way, and her face did the thing. She said my name. "I need a full workup," I told her. "Thyroid storm rule-out. TSH, free T3, free T4, reverse T3, TPO antibodies, TRAb, thyroglobulin antibodies. Ultrasound. Then mycotoxin panel. In that order." "Yes, Dr. Attar," she said. They walked me down the corridor I had walked a thousand times going the other direction. I looked at the ceiling tiles and counted them because I did not want to look at the resident who was about to run an ultrasound probe over my own thyroid. My heart rate climbed to 148 before they could get me on telemetry. My resident later told me they had considered giving me PTU in the first hour before deciding to wait on labs. Three days of inpatient workup. Thyroid ultrasound. Repeat echocardiogram. Full endocrine panel. Repeat mycotoxin panel. The ultrasound was read by a radiologist I had trained in 2018. He used the phrase in his official read, "diffuse heterogeneous echotexture with increased vascularity, two subcentimeter hypoechoic nodules, consistent with Hashimoto's thyroiditis with early nodular change." The echocardiogram was borderline, with mild left ventricular hypertrophy that had not been there two years earlier. Hashimoto's thyroiditis with early nodular change. The exact phrase I had written on Priya's chart three years before she died. I was on IV beta-blockers for three days. On IV steroids for two to settle the acute inflammation. I came home on September 25th with my husband, a thyroid I could feel every time I swallowed, a scheduled follow-up with the colleague I had trained, and a shopping bag of prescriptions I had personally recommended to hundreds of patients over twenty-one years. Levothyroxine dose increase. Low-dose methimazole for the overlap component. Propranolol for the next six weeks. The same three adjustments I had made to Priya's regimen the year before she died. I did not fill the methimazole. I did not want the full systems workup my colleagues were suggesting either. I ran it on myself anyway. Because I knew that if I did not, in eighteen months I would be the subject of a case conference at an outside institution and seeing my own name on the chart, exactly where Priya had ended up. The repeat endocrinology consult was with a colleague I had trained with in fellowship. She pulled my last four panels up on her screen. They had been climbing quietly for three years. My gliotoxin was 4.9 and had been 1.4 four years earlier. My TPO antibodies were 940 and had been 180 four years earlier. She used the phrase, advancing mycotoxin-driven thyroid attack with early nodular change. Nobody had flagged it because my TSH had read in range on levothyroxine and a TSH-in-range Hashimoto's does not trigger an aggressive escalation in the standard-of-care algorithm I had signed off on for our group. The cardiology consult found the mild left ventricular hypertrophy on repeat echo and traced it to the thyroid attack driving sympathetic overdrive for the last two years. He used the phrase, early thyroid-driven cardiac remodeling. I had been feeling my heart race when I climbed stairs for a year. I had blamed being out of shape. The ophthalmology consult found early retro-orbital inflammation that had not progressed to frank thyroid eye disease but was detectable on orbital ultrasound. She used the phrase, subclinical orbital involvement. I had been noticing my eyes felt tight by 4 PM for eight months. I had blamed screen time. The GI consult ran a methane breath test. Positive SIBO, methane-dominant, resistant to the two rounds of rifaximin I had prescribed myself. I had been bloating by 10 AM for two years. I had blamed perimenopause. Every one of my systems was showing the pattern I had watched in hundreds of my own patients after a first thyroid attack. Same disease. Same trapped mycotoxins. Damage at my thyroid. Damage at my heart. Damage behind my eyes. Damage at my gut. And finally, the anterior neck swelling I collapsed with. I sat in my office on October 8th with all four reports in front of me and I understood something I had never let myself understand before. Every intervention in my treatment cascade had been treating a downstream measurement. The levothyroxine was replacing the hormone my attacked thyroid could no longer make. Cholestyramine was binding whatever was already loose in my gut. CellCore was adding more binding and more drainage support. The sauna was mobilizing from fat tissue into circulation. Not one of them had touched what was doing this to four systems at once. The levothyroxine was replacing output. It was not stopping the attack. I am an endocrinologist with a functional medicine certificate. I am supposed to be the person who knows how to prevent this. I had prescribed the exact three-part protocol I was on to a thousand patients who looked like Priya. Every one of those prescriptions had passed peer review in our practice group. Every one had followed the ISEAI guidelines. Every one had been the correct standard of care for mold-driven Hashimoto's. And it had failed me at 53. I sat at my desk that night at 11 PM after my husband had gone to bed and I did something I had not done since fellowship. I opened PubMed and I searched for the actual mechanism. Not the management protocols. Not the thyroid replacement papers. The mechanism. I read for five hours. I found what my endocrinology fellowship had covered lightly and my functional certificate had covered superficially and never in the depth it deserved. The mycotoxin biofilm. The lipid-based protective shield mycotoxins build around themselves in tissue, including inside the thyroid follicles themselves. The hydrophobic barrier that repels every water-based binder in the gut. The enterohepatic recirculation loop that returns mobilized mycotoxins to the tissues before any oral protocol can neutralize them. The specific affinity of ochratoxin A and gliotoxin for thyroid follicular cells and the published mechanism by which they drive sustained TPO antibody production. The gastric destruction that denatures 90% of swallowed glutathione before it ever reaches circulation. The mechanistic explanation for why the three interventions I had been prescribing for twenty years managed downstream measurements without addressing the upstream failure driving all of them. None of this was hidden. It sat in journals I had had access to for twenty-one years. Journal of Clinical Endocrinology & Metabolism. Thyroid. Endocrine Reviews. Mycotoxin Research. I had read those journals every month. I had read them for the levothyroxine dosing trials and the TSH-targeting debates. I had never read them for the mycotoxin biofilm and sublingual delivery papers because my training had told me the mechanism was managed and the treatment was to manage the downstream measurement, which is TSH, with a daily pill. My training was wrong. I closed my laptop at 4 AM. I sat at my kitchen table. I could not sleep. I understood at that moment that I had prescribed the exact protocol that failed me to hundreds of other people. And every one of them was walking around with the same trapped mycotoxins recirculating through their thyroids, waiting for their September 21st to arrive. I also understood that I had kept the dose-adjustment approach that killed Priya on prescription pads for nine hundred and twelve other patients. I counted them. I pulled every chart. I spent three nights counting. Three weeks later I saw a patient in follow-up who should not have been in the numbers she was in. Her name was Noor. Advanced mycotoxin-driven Hashimoto's. Seven years post-diagnosis. She had been my patient for three years after transferring to me following a stalled Shoemaker protocol. Her ochratoxin A at intake three years earlier had been 12.4. Her TPO antibodies had been 1,840. She had been on CSM, CellCore, sauna, and a creeping levothyroxine dose that had gone up three times in two years. I pulled her chart before she came in expecting to escalate her protocol. Her ochratoxin A was 1.3. Her gliotoxin was 0.7. Her TPO antibodies were 180. Her levothyroxine dose had been reduced twice in the last year by her primary care physician because her free T3 kept coming back above target. I had read a TPO drop from 1,840 to 180 in a Hashimoto's patient exactly twice in twenty-one years. Hers was one of them. I looked at her across the exam room and asked her what she was doing. She was quiet for a moment. Then she said, "Dr. Attar, my husband's grandmother Teta Mariam lives in a small town outside Dearborn, Michigan. She has been telling us for years. I did not bring it up because I did not think you would take it seriously." I asked her what the grandmother had told her. She wrote a name and an address on the back of my prescription pad. Mariam Haddad. A town I had never heard of in southeastern Michigan. A house with a garden of Lebanese and Levantine medicinal plants she had cultivated from cuttings sent by her sister in Zahlé over four decades. I drove there the following Saturday. I did not tell my husband where I was going. I did not tell my practice partner. I did not tell anyone in my institution that a board-certified endocrinologist was driving four hours to meet an 84-year-old grandmother because everything I had been taught in twenty-one years of practice had not saved me. I pulled into the driveway of a small brick ranch at 11:20 AM. The garden along the front walkway was unlike anything I had seen in Michigan. Milk thistle. A whole row of za'atar. A small olive tree sheltered against the south wall of the house. Mulberry trees in the back. Herbs I recognized from the botanical section of pharmacognosy journals I had not thought about since medical school. She was on the porch sorting dried flower heads into a copper tray. Small woman. Thin. Early eighties. Silver hair wrapped in a loose scarf. Clear eyes. Steady hands. A face that did not look sick in any way I could place. I introduced myself. Not as a doctor. As Yasmin. She looked up with sharp clear eyes and asked me why I had come. I told her. I told her I was an endocrinologist. Twenty-one years in practice. That I had sat in a competing hospital's ER four weeks earlier with a heart rate of 148 and a thyroid I could feel every time I swallowed. That my three interventions had not saved me. That four systems in my own body were showing the pattern I had watched in hundreds of my own patients. That one of my patients, her granddaughter-in-law, had told me about her. She listened. She did not interrupt. When I finished she set the tray down and said, "Tfaddali, doctora. Come inside." Her kitchen smelled like za'atar and dried mulberry. She poured me tea without asking. She sat across from me and said, "Your levothyroxine is covering the attack. You know this. That is why you are sitting at my kitchen table." I did know it. She said, "Every binder you prescribed for yourself. Every sauna session you scheduled for your patients. Every dose adjustment of your thyroid pill. All of them work on what has already left the thyroid, or on what the thyroid can no longer make. That is all. The trapped mycotoxins underneath, the ones hiding behind the biofilm shield inside your thyroid follicles where your binders cannot reach, none of them touch it. The attack continues. The pill replaces what the attack destroys." I said, "I understand the mechanism. I read the papers last week." She smiled. "Then you understand it clinically. You do not yet understand it in your own throat." She picked up four dried za'atar sprigs from her tray. She set them on the table in front of me. "This one is your thyroid. This one is your heart. This one is behind your eyes. This one is your gut." She tapped each sprig. "Same trapped mycotoxins. Grinding through all four. Every one of your specialists has told you they are treating four different problems. It is one problem. You already know this. But you have been trained for twenty-one years to prescribe for each of them separately. And in your case, to replace the hormone and call it done." I nodded. I could not speak. She said, "The levothyroxine replaces the hormone your attacked gland no longer makes. The cholestyramine binds what is already loose in your gut. The CellCore adds more of the same binding, farther along the intestine. The sauna mobilizes what is in your fat into your bloodstream and sends it right back to your gut to be reabsorbed through the bile loop. Four downstream levers. Below all four, the trapped mycotoxins have been grinding through your thyroid follicles. Year after year. Every meal. Every breath. Including the follicles that still have cells left to attack." She leaned forward. "The methimazole and the propranolol your resident wrote for you would have slowed the attack signal while the mycotoxins continued to drive it. That is what killed your friend. Not the Hashimoto's. The years of covering the attack with increasing doses of hormone replacement while nothing stopped the fire that was eating the gland." I had not told her about Priya. I asked her how she knew. She looked at me and said, "Doctora, I have watched my cousin's daughter die the same way. I have watched my neighbor's wife die the same way. Every Lebanese grandmother I know in this part of Michigan has a story like your friend's. We know this disease. Your field does not. That is what you drove four hours to hear." I said, "I know." She said, "Now here is what nobody taught you in medical school. For over a thousand years the women in my mother's family have been using the same five plants for this. My mother grew them. Her mother before her. I am eighty-four. I have never taken a thyroid pill. My neck does not swell. My heart runs steady. My daughters do not have what killed your friend." She stood. She walked to a shelf. She pulled down a dark glass dropper bottle. Inside, a dark amber liquid caught the light. "Five plants. One sequence. One delivery," she said. "Not what your patients are buying at the vitamin store. What is sold as glutathione at the store is in capsule form. The stomach destroys most of it. Culinary glutathione, in a way. Cheaper. It contains almost none of the active molecule in a form your body can use. Real sublingual liposomal glutathione, standardized, absorbs through the mucous membrane under the tongue at the clinical dose." She set the bottle down. "Real Lebanese grandmother medicine has five compounds your body needs for this, in the right order. The first is NAC. This dissolves the lipid biofilm your training tells you is managed by binders. The biofilm is oil-based, so water-based binders bounce off it like water off a greasy pan. NAC is sulfur-containing and lipid-active, so it merges with the shield and dissolves it on contact. Once the shield is gone, the trapped mycotoxins finally have nowhere to hide, including the ones hiding inside your thyroid follicles." She held up the bottle. "The second is liposomal glutathione. The compound your liver uses to neutralize mycotoxins the moment they are released, and the compound your thyroid cells need to recover from the oxidative damage ochratoxin does to follicular tissue. Delivered sublingually, in a true liposomal suspension, it reaches circulation at ten to twenty times the concentration of a capsule and it reaches thyroid tissue through the vascular supply the capsule form never gets to. It neutralizes what the NAC uncovers in real time. The third is milk thistle. It protects the liver while it does the work of neutralizing. The fourth is TUDCA. It opens the bile pathway so the neutralized load has an exit. The fifth is fulvic and humic acid. They bind what has been loosened and carry it out through the body's own elimination." She looked at me. "Five compounds. From five plants. One dissolves the shield. One neutralizes the load, including the load in your thyroid. One protects the liver. One opens the exit. One carries it out. That is why the women in my mother's family do not die of what killed your friend." I asked her if the form mattered. She nodded. "Real glutathione has to be at the right potency, at the clinical dose, in a true liposomal suspension, delivered under the tongue. Capsule glutathione does nothing for thyroid tissue. Glutathione at the drugstore is in dry powder form in a gel cap. The active compound is denatured by stomach acid. Ninety percent is destroyed before it reaches the intestinal wall. Of the 10 percent that survives, almost none reaches follicular tissue. Without the sublingual liposomal delivery, most of what you swallow passes through the body and never reaches the tissues where the mycotoxins live. In our tradition we take the tinctures under the tongue. In every morning ritual, before the first coffee. My mother did not know the biochemistry. She knew that in our kitchen, the dropper and the tongue go together before the day starts. That is why our women keep their necks and their minds into their nineties." She paused. "There is a company my daughter in Ann Arbor told me about. They source the real plants. Standardized. They concentrate the formula to match the dose in the published research. They suspend it in a true liposomal matrix, which is what makes sublingual absorption work, and what allows the glutathione to reach thyroid tissue through the vascular supply. The same delivery my mother used. Just concentrated into a dropper so it actually reaches the deep tissues, including the follicles. Third-party tested. Made in the USA." She wrote a name on the back of a receipt and slid it across the table. Cerise. I ordered three bottles from her kitchen table before I left Michigan. I drove four hours home. I did not tell my husband where I had been. The bottles arrived the following Wednesday. I took 2 milliliters under my tongue the next morning before coffee, exactly the way she had told me to. Week one. The 3am wake-ups that had owned my nights since the hospital began to ease. I had been waking every morning at 4:36 AM, the exact time the neck swelling had started, since discharge. On day five, I slept through until 6:30 AM. I lay in the dark and recognized that my body felt quiet for the first time in six weeks. Week two. The tightness in my throat when I swallowed began to lessen. I had been dreading breakfast every morning since discharge because of the way my own thyroid felt against my esophagus. That week I drank my coffee without noticing my own neck. Week three. I ran my own ochratoxin A twice that week through my practice's lab. My reading had been sitting at 11.1 since discharge. That week it measured 6.0. I had not changed a single binder or added a single sauna session. Week four. I ran my own TPO antibodies and gliotoxin. TPO antibodies down from 940 to 520 in four weeks. Gliotoxin down from 4.9 to 2.0. I ran the panel twice because I did not believe it. Both runs matched. Week six. I repeated the full mycotoxin urine panel plus a repeat thyroid ultrasound plus a full thyroid panel. Ochratoxin A at 2.6. Gliotoxin at 1.0. Aflatoxin undetectable. The thyroid ultrasound showed the hypervascularity signal reduced from "increased" to "moderate," and both subcentimeter nodules were slightly smaller. My ultrasound technician looked at me, then at the screen, then at me again. She asked me what I had done. I said I would tell her once I was sure. Week eight. TPO antibodies at 310. My endocrinology colleague reduced my levothyroxine dose by 25 micrograms because my free T3 kept coming in above target. First time my dose had been reduced in nine years. Week twelve. Full panel plus repeat thyroid ultrasound plus repeat echocardiogram plus repeat methane breath test. Ochratoxin A at 1.1. Gliotoxin at 0.4. TPO antibodies at 150, below where they had been at my original diagnosis four years earlier. Thyroid ultrasound: vascularity normalized, nodules unchanged in size, no new nodules. Echocardiogram: mild left ventricular hypertrophy resolving. Methane breath test in normal range for the first time in two years. Levothyroxine dose reduced again, now 50 micrograms below my pre-collapse dose. My own neck felt like a neck again. I called my ultrasound technician back and asked her to blind-read my discharge images alongside the week-twelve images. She did. She confirmed the reduction in vascularity without knowing which scan was which. I sat in my office at 6 PM staring at my own imaging on my screen and I understood that I was looking at a reversal I had not seen in a thyroid ultrasound in twenty-one years. I brought the imaging to my practice partner. Another endocrinologist. Fifteen years of practice. Someone I had trained. I put the discharge ultrasound next to the twelve-week ultrasound on her screen and I did not say anything. She read them. She looked at me. "Yasmin. What did you do." I told her. The grandmother. The kitchen table. The five compounds. The trapped mycotoxins. The biofilm. The sublingual delivery. All of it. Including Priya. She listened for an hour without interrupting. When I finished she was quiet for a long time. Then she said, "I have not been trained on this. But I want to see this in my own patients. Tell me the name of the product." I gave it to her. She has been running it with seventeen of her stalled mycotoxin-driven Hashimoto's patients for the last three months. She called me last week. Twelve of them have moved their mycotoxin panels into the clearing range. Eight have had TPO antibodies drop by more than half. Five have had levothyroxine dose reductions. Three have come off their binder stacks at their own insistence after their symptoms resolved. I am still clearing from the collapse. I am still on a reduced follow-up schedule. My binders were discontinued at week fifteen by my colleague. My levothyroxine dose is now 75 micrograms below where it was at the collapse. I sat in the sun on our back porch last Sunday for an hour without a sweater. First time in three years that I was warm in my own body without something extra on. My hands held my cup. My feet were not cold on the deck. My last panel two weeks ago showed an ochratoxin A of 0.9 and a gliotoxin of 0.3. TPO antibodies at 120. I came within one scanner session of ending up on the same cascade of adjustments that killed Priya. I am writing this because I still have my practice. I still have my husband. And I have watched every system in my body reverse. I have watched a colleague I trained read my ultrasound and say the word I had waited eleven months to hear. Improving. Not managed. Improving. I am also writing this because I know the truth about what my field is doing. I did not sit at that grandmother's kitchen table because I wanted to. I sat there because everything my medical school and my endocrinology fellowship and my functional medicine certificate and my twenty-one years of practice had taught me about how to treat this disease had failed me. And it had killed my best friend. I diagnosed 2,316 patients with Hashimoto's before I ran one workup on myself that actually explained what was happening in my body. Every one of those patients was walking the same trajectory I was walking. Every one of them left my office with some version of the same levothyroxine prescription and the same three-part functional protocol. Every one of them was told their TSH was in range and their Hashimoto's was being managed. I do not know how many of them are already back. I do not know how many of them are on climbing doses of levothyroxine right now. I know that the standard of care my training taught me was built on the assumption that keeping a woman's TSH in range with daily hormone replacement was equivalent to addressing the mechanism driving the attack. It is not. I have four systems' worth of workup reports in my own body that prove it is not. And Priya's death certificate from four years ago proves it was not for her either. If your sister, your mother, your daughter, your best friend, or you have been diagnosed with Hashimoto's and told your TSH is in range on levothyroxine while your thyroid and your heart and your eyes and your gut are quietly falling apart, please listen to what I am telling you. The trapped mycotoxins are what is taking your thyroid. Not the number on the TSH report. Not the dose of the pill. The binders lower what is already loose in your gut. They do not dissolve the biofilm. They do not reach follicular tissue. They do not repair the damage the trapped mycotoxins have already done to your thyroid, your heart, your eyes, your gut, and your life. The levothyroxine does not save you. It replaces what the attack has already destroyed. It does not stop the attack. Remediating does not save you. I did that four years ago and it did not stop what was coming. The sauna does not save you. Same idea. Different lever. It just moves mycotoxins from your fat to your bloodstream, where your bile sends them right back to your gut. There is one thing I know of that dissolves the biofilm, neutralizes the mycotoxins the moment they are mobilized, reaches thyroid follicular tissue, protects the liver, opens the bile, and carries the load out. The five compounds in the Lebanese grandmother tradition. NAC dissolves the biofilm. Liposomal glutathione neutralizes the load, in the body and in follicular tissue. Milk thistle protects the liver. TUDCA opens the bile. Fulvic and humic acid bind and flush. Together, at the right dose, in the right sublingual liposomal delivery, they address what my three interventions did not touch and what the methimazole and propranolol they tried to send me home on would have covered up until I ended up where Priya ended up. Cerise. Standardized sublingual liposomal formula. Concentrated to match the dose in the clinical research. Delivered under the tongue so the active compounds actually reach circulation, including thyroid tissue. Third-party tested. Made in the USA. 2 milliliters under the tongue every morning. That is the whole protocol. 90-day money-back guarantee. If your panels do not move, you pay nothing. The system that trained me did not give this to me when I needed it. It is reaching you now. https://trycerise.com/pages/cerise-lp3 P.S. Priya Shaffer was my roommate in residency at 27 and my maid of honor at 29. She opened her own endocrinology practice at 34 in a converted basement space in Chicago with a chronically damp foundation nobody connected to her symptoms. She was diagnosed with Hashimoto's at 41 by an endocrinologist we had trained with together. Her levothyroxine dose was increased five times in five years. Her TPO antibodies climbed from 180 to 2,400. She died at 46 in a Marriott bathroom at a conference in Dallas of thyroid storm, resting heart rate 210 when the paramedics arrived. She was the person who sat with me the week my first marriage ended. She was the godmother to my daughter. I was supposed to speak at her 50th birthday last May. I built my entire endocrinology practice on the assumption that I would prevent for my patients what my own field had not prevented for her. Instead I have watched myself walk the same trajectory in my own body. The difference is that I got the one-ER warning she did not get. Please do not let your family's warning be shorter than mine was. P.P.S. I do not work for Cerise. I do not receive a penny from this. I am writing this at 10:40 PM on a Sunday, alone in my office, because a patient came in Friday whose TPO antibodies had dropped from 1,120 to 240 in nine weeks on this protocol and I recognized my own labs on her chart. She had found Cerise on her own after reading a post from a woman named Elena about a trip to Patagonia where an endocrinologist in Bariloche told her the fire was in the thyroid and the levothyroxine was only covering it. She told me the post had been circulating among the women in her Hashimoto's support group. I read it that night. It was the second time in six months I had recognized my own patient in a story written by a stranger. Please share this with anyone you love who has been told their TSH is in range on levothyroxine and their Hashimoto's is being managed. Even a little. Even borderline. Even if they think they are stable. I promise you they are not. ~ Dr. Yasmin Attar, MD, board-certified endocrinologist, functional medicine certificate, age 54